Treatment of Prostate Inflammation (Prostatitis)
For bacterial prostatitis, fluoroquinolones (ciprofloxacin or levofloxacin) are first-line therapy, with treatment duration of 4-6 weeks for chronic bacterial prostatitis and 2 weeks minimum for acute bacterial prostatitis; for chronic pelvic pain syndrome without infection, use multimodal therapy targeting specific symptom domains rather than antibiotics. 1
Distinguish the Type of Prostatitis First
The treatment approach fundamentally depends on whether this is bacterial or non-bacterial prostatitis:
Acute Bacterial Prostatitis (ABP)
- Do NOT perform prostatic massage - this can precipitate bacteremia 1
- Take mid-stream urine culture and blood cultures to guide therapy 1
- Consider transrectal ultrasound only if prostatic abscess is suspected 1
Initial treatment for severe cases:
- Start IV fluoroquinolone (ciprofloxacin 400 mg twice daily or levofloxacin 500 mg daily) 1, 2
- Alternative IV options: third-generation cephalosporins, aminoglycosides with ampicillin, or piperacillin-tazobactam 1
- For multiresistant pathogens, use meropenem 3
- Treatment duration: minimum 2 weeks, as prostatic involvement is frequent in men with febrile UTI 1
Chronic Bacterial Prostatitis (CBP)
Diagnosis requires:
- Perform the Meares-Stamey 4-glass test or simplified 2-glass test to localize infection 1, 2
- Obtain accurate microbiological evaluation including atypical pathogens (Chlamydia trachomatis, Mycoplasma genitalium) 1, 3
Treatment regimens:
- First-line: Fluoroquinolones for 4-6 weeks (ciprofloxacin or levofloxacin at optimal oral doses) 1, 2
- These achieve ~70% cure rates due to excellent prostatic penetration 3
- For Chlamydia or Mycoplasma: Doxycycline 100 mg twice daily for 10 days OR Azithromycin 500 mg daily for up to 3 weeks 1
- Macrolides are more effective than fluoroquinolones for intracellular pathogens 3
- For Trichomonas vaginalis: Metronidazole 500 mg three times daily for 14 days 1
- For fluoroquinolone-resistant infections: Consider aminoglycosides or fosfomycin 3, 2
Critical caveat: Avoid repeated fluoroquinolone courses if cultures don't support infection or there's no symptomatic benefit 4
Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
This represents the majority of prostatitis cases and is NOT primarily infectious. The 2025 AUA guideline emphasizes this requires multimodal therapy, not antibiotics 5.
Symptom-Based Treatment Algorithm:
For patients with voiding symptoms (LUTS):
- Offer alpha-blockers (alfuzosin, doxazosin, silodosin, tamsulosin, terazosin) 5
- Note: Large RCTs show conflicting results, but clinical benefit in select patients with voiding dysfunction 5
For pain management:
- Simple analgesics and NSAIDs for short-term use (limited by side effects with long-term use) 3
- Early consideration of neuropathic pain medications for non-responders 4
- Phytotherapy options: Quercetin, pollen extract, Serenoa repens - these show positive effects on symptoms without side effects 3
Behavioral/lifestyle modifications:
- Discuss dietary changes: avoid spicy foods, coffee, tea, chili, alcohol if sensitive 5
- Increase fruits, vegetables, water, fiber (docusate, psyllium) 5
- Recommend aerobic exercise 5
Multimodal combination therapy:
- Combining alpha-blockers, anti-inflammatories, and targeted therapies shows better symptom control than monotherapy 3
- Consider pelvic floor physical therapy, especially if muscle tension present 5
- Address psychological components and sexual dysfunction (present in 46-92% of cases) 3
UPOINT Phenotyping System
Use this to guide multimodal therapy by identifying specific domains:
- Urinary symptoms → alpha-blockers
- Psychosocial factors → cognitive behavioral therapy
- Organ-specific findings → targeted therapy
- Infection → appropriate antimicrobials
- Neurological/systemic → neuropathic pain medications
- Tenderness of muscles → pelvic floor physical therapy
- Sexual dysfunction → address specifically
This approach achieves 75-84% symptom improvement 6
Key Pitfalls to Avoid
- Don't use prolonged antibiotics for CP/CPPS without documented infection - this drives resistance and is ineffective 5, 4
- Don't perform prostatic massage in acute bacterial prostatitis - risk of bacteremia 1
- Don't assume all prostatitis is bacterial - only ~10% of chronic cases have identifiable pathogens 7
- Don't use nitrofurantoin, oral fosfomycin, or pivmecillinam for prostatic infections - inadequate prostatic penetration 1
- Refer early to specialists/MDT if initial measures fail rather than cycling through ineffective antibiotic courses 4